NORTHERN DYNASTY MINERALS (NAK)       0.3  +0 (+1.35%)

0.3  +0 (+1.35%)

CA66510M2040 - Common Stock - After market: 0.3002 +0 (+0.07%)


Fundamental Rating

We assign a fundamental rating of 3 out of 10 to NAK. NAK was compared to 1003 industry peers in the Metals & Mining industry. While NAK has a great health rating, but there are worries on its profitability. While showing a medium growth rate, NAK is valued expensive at the moment.




Profitability

Profitability Rating


NAK has a Piotroski-F score of 4.00. This indicates an average health and profitability for NAK.
NAK has negative profitability rations, so we won't be analyzing them here.

NAK has a Return On Assets of -19.80%. This is below the industry average of -11.45%.
VS Industry

ROA (-19.8%) VS Industry: 37% outperformed.

-58,568.82
16,422.17

Valuation

Valuation Rating


When comparing the price book ratio of NAK to the average industry price book ratio of 1.83, NAK is valued rather cheaply.
When comparing the current price to the book value of NAK, we can conclude it is valued correctly. It is trading at 1.33 times its book value.

NAK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NAK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
VS Industry

Price/Book (1.33) VS Industry: 63% outperformed.

4,559.00
0.15

Growth

Growth Rating


The Earnings Per Share has grown by an impressive 54.61% over the past year.
NAK is expected to show quite a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 12.14% yearly.

NAK is expected to show a very negative growth in Revenue. In the coming 5 years, the Revenue will decrease by -18.92% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 54.61% 66.33% 22.27% 9.88% 12.14%
RevenueN/A N/A N/A -100% -41.42% -25.99% -18.92%

Health

Health Rating


A Current Ratio of 9.97 indicates that NAK has no problem at all paying its short term obligations.
When comparing the Current Ratio to an average industry Current Ratio of 3.60, NAK is better placed than the average industry peer to meet its short term obligations.
NAK has a Quick Ratio of 9.97. This indicates that NAK is financially healthy and has no problem in meeting its short term obligations.
When comparing the Quick Ratio to an average industry Quick Ratio of 3.19, NAK is better placed than the average industry peer to meet its short term obligations.

An Altman-Z score of 26.77 indicates that NAK is not in any danger for bankruptcy at the moment.
NAK is in better financial health than average in its industry. Its Altman-Z score is much better than the industry average of 3.44.
The Piotroski-F score of NAK is 4.00. This is a neutral score and indicates average health and profitability for NAK.
Compared to an average industry Debt to Equity Ratio of 0.00, NAK is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0) VS Industry: 37% outperformed.

29.83
-90.09

Quick Ratio (9.97) VS Industry: 75% outperformed.

0.00
703.43

Current Ratio (9.97) VS Industry: 75% outperformed.

0.00
703.43

Altman-Z (26.77) VS Industry: 79% outperformed.

-72,242.07
708,925.94

Dividend

Dividend Rating


No dividends for NAK!.

NAK Daily chart

NORTHERN DYNASTY MINERALS0.3

NYSEARCA:NAK (5/16/2022, 4:25:25 PM)+0 (+1.35%)

After market: 0.3002 +0 (+0.07%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Metals & Mining
Earnings (Last) 11-26 2021-11-26/bmo Earnings (Next) N/A N/A
Ins Owners N/A Inst Owners 12.97%
Market Cap 158.93M Analysts 80
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S N/A P/B 1.33
EV/EBITDA -5.9
Profitability
ROA -19.8% ROE N/A
PM N/A Asset Turnover N/A
Growth
EPS 1Y 54.61% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 100%
EPS Next Y 66.33% EPS Next 2Y 22.27%
EPS Next 3Y 9.88% EPS Next 5Y 12.14%
Revenue growth 1Y N/A Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year -100% Revenue Next 2Y -41.42%
Revenue Next 3Y -25.99% Revenue Next 5Y -18.92%
Health
Current Ratio 9.97 Quick Ratio 9.97
Altman-Z 26.77 F-Score 4
Debt/Equity 0
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA